Clinical Trials Browser

Completed × giredestrant × 90 days × Clear all

NCT05659563 2026-03-19

EMPRESS

Phase 2 Completed

92 enrolled 14 charts

Breast Neoplasms

NCT05896566 2026-02-24

PREcoopERA

Phase 2 Completed

Breast Neoplasms